The Fuctionality of Ipamorelin

Posted on October 3, 2013 by Maxim Peptide

Ipamorelin is a secretagogue peptide, meaning that can play a role in
energy homeostatis as well as the regulation and control of body
weight in animal test subjects. It is similar to the peptide GHRP!,
with one of the chief differences being that Ipamorelin is a penta
peptide as opposed to a he"apeptide. In other words, the peptide
consists of fi#e sides instead of si". It is considered to be an agonist,
meaning that it has the capability to bind to certain receptors of a cell
and induces a cellular response. The peptide is administered to
animal test subjects #ia subcutaneous injection as part of ongoing
scientific research in relation to studying its operational mechanisms
and properties.
The Fuctionality of
Ipamorelin
$ccording to scientific research conducted on animal test subjects,
the primary function of Iparmorelin is to stimulate the pituitary gland.
This is the peasi%ed gland found at the base of the brain that is responsible for regulating an organism&s
endocrinebased functionality. These #arious functions include'
Regulation of bodily growth
Regulation of hyroid gland function
Regulation of blood pressure
Pain relief
Regulation of temperature
Part of Ipamorelin&s functionality is that it stimulates the production of a hormone that is secreted by the pituitary
gland of animal test subjects. $t the same time, the Ipamorelin has been shown through scientific research
conducted on animal test subjects to inhibit the production of somatostatin( a peptide that is chiefly responsible for
bloc)ing the release of some hormones. $dditionally, the peptide has been shown to increase the production of
IGF*. This hormone, also )nown as Insulin+i)e Growth Factor * or somatomedin ,, is similar in the molecular
build of insulin which is secreted in animal test subjects as an endocrine hormone, which through scientific
research as determined to be the chief anabolic mechanism of action for some hormones. This portion of the
peptide&s functionality ma)es it similar to the operational tendencies of GHRP!. Howe#er, unli)e the GHRP!,
Ipamorelin wor)s to bind to major control points of appetite, gastric, and growth motility. In other words, scientific
research on animal test subjects ha#e determined that the peptide does not induce an increase in hunger le#els,
Click here to buy Ipamorelin 2000mcg in our store
which has been determined to be an effect found in GHRP!.
-cientific studies on animal test subjects also show that Ipamorelin does not significantly increase the production
le#els of cortisol( the hormone found in animal test subjects that increases blood sugar through the process of
gluconeogenesis. It also does not significantly increase the production le#els of prolactin( the hormone that is plays
an important role in regulating the immune system of animal test subjects, primarily as it relates to the process of
lactation.
Benefits of Ipamorelin
-cientific research that has been conducted on animal test subjects has determined se#eral different theoretical
benefits that ha#e been lin)ed to Ipamorelin. These theoretical benefits include'
Increased fat loss
Reju#enation of joints
-trengthening of joints
-trengthening of connecti#e tissue
-trengthening of bone mass
Impro#ed s)in tone
These types of positi#e benefits ha#e led some scientific studies to determine that the peptide could carry se#eral
theoretical benefits as they relate to the slowing down of the aging process.
Side Effects of Ipamorelin
The negati#e side effects of Ipamorelin, according to scientific research that has been conducted on animal test
subjects, are determined to be minimal. These negati#e side effects primarily ha#e been )nown to consist of
headaches and head rushes .also referred to as a feeling of lightheadedness/. The research that has been
conducted on animal test subjects has determined that these side effects are relati#ely mild in nature. Furthermore,
the list of negati#e side effects has been determined to be significantly shorter than the list of side effects that are
typically associated with the peptide GHRP!.
For Clinical Research Only
0hile scientific study conducted on animal test subjects ha#e determined a basic outline relating to the operational
mechanisms and functionality of Ipamorelin, it should be noted that wor) with the peptide is still currently confined
to the research stage. $ny positi#e benefits or negati#e side effects that ha#e been documented through scientific
research on animal test subjects is still a product of research that is still ongoing and not conclusi#e. Therefore, it is
crucial to note that any obser#ation or findings regarding Ipamorelin in relation to its o#erall mechanisms,
operational properties, positi#e benefits, or negati#e side effects should be contained to the confines of a strictly
controlled en#ironment such as a laboratory or a research facility.